Hudson River Biotechnology raises €5m Series A funding to accelerate growth of its plant gene editing business and expand into nanoparticles for use in field applications
Ferdinand Los, CSO at Hudson River Biotechnology: “We strongly believe in our ability to keep innovating and be at the forefront of technological developments. This
Opinion piece in Agfunder: A sole focus on organic farming will not get us where we need to be
In an opinion piece on AgFunder, our founders Rudi Ariaans and Ferdinand Los argue that CRISPR is the best tool the EU has to achieve its ambitious agrifood sustainability goals.
Company profile of Hudson River Biotechnology in Bionieuws
Bionieuws, the Dutch magazine for biologists interviewed our CSO Ferdinand Los, and published a short company profile in their magazine. Read the article here.
Prof. John van der Oost joins Hudson River Biotechnology’s Advisory Board
Prof. John van der Oost, head of the Bacterial Genetics group in the Laboratory of Microbiology at Wageningen University, has joined the Scientific Advisory Board
Hudson River Biotechnology (HRB) names Gabino Sánchez as Sales & Business Development Director.
>> download a pdf version of the press release
Hudson River Biotechnology named as one of the 15 most promising startups in Europe
>> download a pdf version of the press release
Hudson River Biotechnology opens up new laboratory
Wageningen-based CRISPR start-up continues strong growth Hudson River Biotechnology (HRB) opens up a state-of-the-art laboratory in Wageningen to facilitate its ground-breaking research in precision plant
Hudson River Biotechnology raises seed investment round
Wageningen-based CRISPR start-up accelerates growth Hudson River Biotechnology (HRB) has raised a strategic investment round, fully funding its current business plan and bringing in a